WATCH NOW
Solid Biosciences Webinar | May 2026
On May 26, 2026, Solid Biosciences’ Matthew Harmelink, MD, Therapeutic Area Head of Neuromuscular, and Seth Rotberg, Senior Manager of Patient Advocacy, joined FARA to provide an update about Solid’s FALCON gene therapy (SGT-212) phase 1b study.
